Nebius (NBIS) › Analysis

Nebius (NBIS) stock analysis, December 5, 2025: NBIS tests $100 four times as 259% YTD gain meets profit-taking

Published December 5, 2025 · NBIS chart, levels and live analysis

Key Updates

Nebius shares declined -2.66% to $99.50, surrendering the $100 psychological level established just yesterday and marking the second pullback in three sessions. The retreat follows publication of a comprehensive bull case analysis that highlights the company's ambitious 2026 ARR targets but does not introduce material new catalysts. The stock's inability to sustain above $100 despite maintaining a 259.21% YTD gain and securing over $20 billion in hyperscaler contracts signals near-term profit-taking after the recent rebound from November lows. The investment thesis remains fundamentally intact, anchored by transformational Microsoft ($17.4B) and Meta ($3B) deals, though execution risk and valuation concerns continue to weigh on sentiment.

Current Trend

Nebius maintains a powerful 259.21% YTD advance despite recent volatility, positioning it among the year's top-performing technology stocks. The shares have established a clear pattern: a 35% decline from all-time highs above $130 in November, followed by a double-digit rebound that peaked at $102.22 on December 4th. The current $99.50 level represents critical technical territory—the stock has now tested $100 four times in recent sessions without establishing it as durable support. The 5-day gain of 4.88% demonstrates resilience, while the 1-month decline of -14.96% reflects broader AI infrastructure sector repricing. The 6-month surge of 114.90% underscores the transformational impact of hyperscaler contract announcements. Resistance now sits at $102-105, with support at $90-95 based on recent trading patterns.

Investment Thesis

The investment case centers on Nebius's emergence as a pure-play AI infrastructure provider with validated demand from hyperscale customers. The company targets 2025 ARR of $900M-$1.1B and 2026 ARR of $7B-$9B, representing an extraordinary 6-8x revenue acceleration driven by the Microsoft and Meta contracts. Analysts project 61%-159% upside potential based on the company's trajectory toward EBITDA profitability and nearly full utilization of computing capacity. The consensus Strong Buy rating with an average price target of $164 implies 65% upside from current levels. However, the thesis requires successful execution of aggressive capital expenditure plans exceeding $4.5 billion in debt, navigation of circular financing concerns, and sustained AI infrastructure demand through 2026. The company's ability to deliver on its $7-9B ARR target by end-2026 represents the critical thesis validation point.

Thesis Status

The core investment thesis remains on track but faces near-term validation challenges. No new fundamental developments emerged today to alter the strategic picture established by the Microsoft and Meta contracts. The -2.66% decline reflects technical consolidation rather than thesis deterioration. Recent bull case analysis reaffirms the 2026 ARR growth surge opportunity but does not introduce incremental positive catalysts. The stock's 7.2% outperformance versus the S&P 500's 4.3% gain since the previous Seeking Alpha report demonstrates continued investor conviction. Critical near-term thesis tests include: (1) maintaining contract execution momentum, (2) demonstrating progress toward EBITDA profitability in upcoming quarters, (3) securing additional hyperscaler commitments beyond Microsoft and Meta, and (4) managing dilution and leverage concerns that have drawn investor scrutiny. The upcoming UBS Global Technology and AI Conference on December 3rd (already occurred based on previous reports) provided management visibility but appears not to have generated material new catalysts. Thesis remains valid but requires operational delivery to justify current valuation multiples.

Key Drivers

The primary catalyst structure remains unchanged from previous sessions. The 2026 ARR growth surge narrative continues to drive institutional positioning, with the company targeting $7-9B in annualized revenue by end-2026 versus current $900M-$1.1B guidance for 2025. Hedge fund and institutional buying accelerated following the November selloff, with smart money viewing the 30% decline as an attractive entry point. The Microsoft $17.4B and Meta $3B contracts provide multi-year revenue visibility and validate Nebius's competitive positioning in AI cloud infrastructure. Valuation concerns persist with the stock trading at 5x price-to-book versus the US Software industry average of 3.4x, though cheaper than peer group average of 10.8x. Analyst price targets have moderated from $166 to approximately $159, reflecting tempered expectations balanced against strong contract momentum. The absence of new contract announcements or operational updates today allowed profit-taking to dominate price action.

Technical Analysis

Nebius exhibits classic consolidation behavior after testing the $100 psychological barrier four times in recent sessions. The current $99.50 level sits at the lower boundary of a $99-$102 trading range established over the past three days. Volume patterns suggest institutional distribution near $102 and accumulation near $95, creating a narrow band for near-term price discovery. The 5-day gain of 4.88% demonstrates buyers remain engaged on dips, while the 1-month decline of -14.96% reflects the November correction from $130+ levels. Key resistance sits at $102 (yesterday's high), $105 (minor resistance), and $110-115 (gap fill zone). Critical support levels include $95 (November rebound low), $90 (strong institutional buying zone), and $83 (recent monthly low). The 50-day moving average likely resides near $95 based on the 6-month chart pattern, providing dynamic support. Relative strength remains positive given the 259.21% YTD performance, though momentum indicators have likely rolled over from overbought conditions. A decisive break above $102 would target $110-115, while failure to hold $95 could retest the $90 support zone where hedge funds previously accumulated shares.

Bull Case

Bear Case

Get a message when the NBIS picture changes — the agent team watches the levels and the news for you.Create a free account

More NBIS analyses